Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Long-term study shows benefits of statins in reducing heart disease deaths

Long-term study shows benefits of statins in reducing heart disease deaths

7th September 2017

Long-term use of statins to reduce cholesterol can have a significant impact on reducing heart disease-related deaths.

This is according to a new study from Imperial College London and the University of Glasgow, which has analysed 20 years of data from 5,529 men to assess the benefits of a daily dose of pravastatin on heart disease rates.

It was shown that this relatively weak type of statin proved effective in controlling levels of low-density lipoprotein (LDL) cholesterol, with men with very high levels of LDL seeing their 20-year mortality rates cut by 18 percent thanks to the therapy.

Statins were also shown to reduce the overall risk of death by coronary heart disease by 28 percent, while the risk of death from other cardiovascular diseases was reduced by 25 percent among those with very high LDL cholesterol.

This represented the longest ever study of statin use for cholesterol reduction, and offers strong evidence of the benefits statins can provide.

Study leader Professor Kausik Ray, from Imperial College London's School of Public Health, said: "Our study lends support to LDL's status as a major driver of heart disease risk, and suggests that even modest LDL reductions might offer significant mortality benefits in the long term."

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801839682-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.